Ndiaye et al. assessed the expression and localization of ACSL3 and ACSL4 in HCC, cholangiocarcinoma (CCA), and hepatic metastases by performing IHC analyses on tissue microarrays and subcellular fractionation of HepG2 cells [275]. This evidence concerns the gene ACSL3 and cholangiocarcinoma.